112 related articles for article (PubMed ID: 9242365)
1. Actinomycin D treatment leads to differentiation and inhibits proliferation in rhabdomyosarcoma cells.
Marchal JA; Prados J; Melguizo C; Fernández JE; Vélez C; Alvarez L; Aránega A
J Lab Clin Med; 1997 Jul; 130(1):42-50. PubMed ID: 9242365
[TBL] [Abstract][Full Text] [Related]
2. Low concentrations of actinomycin D potentially cause therapeutic differentiation in human rhabdomyosarcoma cell line RD.
Melguizo C; Prados J; Marchal JA; Aránega AE; Alvarez L; Aránega A
Pathol Res Pract; 1996 Feb; 192(2):188-94. PubMed ID: 8692721
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic differentiation in a human rhabdomyosarcoma cell line selected for resistance to actinomycin D.
Prados J; Melguizo C; Marchal JA; Vélez C; Alvarez L; Aránega A
Int J Cancer; 1998 Jan; 75(3):379-83. PubMed ID: 9455797
[TBL] [Abstract][Full Text] [Related]
4. Actinomycin D causes multidrug resistance and differentiation in a human rhabdomyosarcoma cell line.
Melguizo C; Prados J; Fernández JE; Vélez C; Alvarez L; Aránega A
Cell Mol Biol (Noisy-le-grand); 1994 Mar; 40(2):137-45. PubMed ID: 7911694
[TBL] [Abstract][Full Text] [Related]
5. Ara-C treatment leads to differentiation and reverses the transformed phenotype in a human rhabdomyosarcoma cell line.
Crouch GD; Kalebic T; Tsokos M; Helman LJ
Exp Cell Res; 1993 Feb; 204(2):210-6. PubMed ID: 8440318
[TBL] [Abstract][Full Text] [Related]
6. Inverse expression of mdr 1 and c-myc genes in a rhabdomyosarcoma cell line resistant to actinomycin d.
Prados J; Melguizo C; Fernández A; Aránega AE; Alvarez L; Aránega A
J Pathol; 1996 Sep; 180(1):85-9. PubMed ID: 8943821
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of a human rhabdomyosarcoma cell line after antineoplastic drug treatment.
Melguizo C; Prados J; Aneiros J; Fernandez JE; Velez C; Aranega A
J Pathol; 1995 Jan; 175(1):23-9. PubMed ID: 7891223
[TBL] [Abstract][Full Text] [Related]
8. GR-891: a novel 5-fluorouracil acyclonucleoside prodrug for differentiation therapy in rhabdomyosarcoma cells.
Marchal JA; Prados J; Melguizo C; Gómez JA; Campos J; Gallo MA; Espinosa A; Arena N; Aránega A
Br J Cancer; 1999 Feb; 79(5-6):807-13. PubMed ID: 10070873
[TBL] [Abstract][Full Text] [Related]
9. Uncoupling of growth inhibition and differentiation in dexamethasone-treated human rhabdomyosarcoma cells.
De Giovanni C; Lollini PL; Dolcetti R; Landuzzi L; Nicoletti G; D'Andrea E; Scotland K; Nanni P
Br J Cancer; 1993 Apr; 67(4):674-9. PubMed ID: 8471424
[TBL] [Abstract][Full Text] [Related]
10. Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines.
Codenotti S; Poli M; Asperti M; Zizioli D; Marampon F; Fanzani A
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1717-1730. PubMed ID: 29971532
[TBL] [Abstract][Full Text] [Related]
11. Actin, tropomyosin and alpha-actinin as markers of differentiation in human rhabdomyosarcoma cell lines induced with dimethyl sulfoxide.
Prados J; Melguizo C; Fernandez JE; Aranega AE; Alvarez L; Aranega A
Cell Mol Biol (Noisy-le-grand); 1993 Jul; 39(5):525-36. PubMed ID: 8374504
[TBL] [Abstract][Full Text] [Related]
12. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of new 5-fluorouracil antitumor cell differentiating derivatives.
Domínguez JF; Marchal JA; Correa A; Carrillo E; Boulaiz H; Aránega A; Gallo MA; Espinosa A
Bioorg Med Chem; 2003 Feb; 11(3):315-23. PubMed ID: 12517427
[TBL] [Abstract][Full Text] [Related]
14. Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells.
Astolfi A; De Giovanni C; Landuzzi L; Nicoletti G; Ricci C; Croci S; Scopece L; Nanni P; Lollini PL
Gene; 2001 Aug; 274(1-2):139-49. PubMed ID: 11675006
[TBL] [Abstract][Full Text] [Related]
15. Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and actinomycin D induces apoptosis even in TRAIL-resistant human pancreatic cancer cells.
Matsuzaki H; Schmied BM; Ulrich A; Standop J; Schneider MB; Batra SK; Picha KS; Pour PM
Clin Cancer Res; 2001 Feb; 7(2):407-14. PubMed ID: 11234897
[TBL] [Abstract][Full Text] [Related]
16. Modulation of myogenic differentiation in a human rhabdomyosarcoma cell line by a new derivative of 5-fluorouracil (QF-3602).
Marchal JA; Melguizo C; Prados J; Aránega AE; Gómez JA; Campos J; Gallo MA; Espinosa A; Arena N; Aránega A
Jpn J Cancer Res; 2000 Sep; 91(9):934-40. PubMed ID: 11011122
[TBL] [Abstract][Full Text] [Related]
17. Low sample volume causes differentiation in human rhabdomyosarcoma cell line RD subjected to electroporation.
Aránega A; Marchal JA; Melguizo C; Prados J; Aránega AE; Vélez C; Fernández JE; Arena N; Alvarez L
Cell Mol Biol (Noisy-le-grand); 1996 Dec; 42(8):1219-27. PubMed ID: 8997525
[TBL] [Abstract][Full Text] [Related]
18. Novel anticancer function of inositol hexaphosphate: inhibition of human rhabdomyosarcoma in vitro and in vivo.
Vucenik I; Kalebic T; Tantivejkul K; Shamsuddin AM
Anticancer Res; 1998; 18(3A):1377-84. PubMed ID: 9673344
[TBL] [Abstract][Full Text] [Related]
19. cAMP effects on myogenic gene expression in rhabdomyosarcoma cells.
Wasserman LM; Newsham I; Huang HJ; Cavenee WK
Exp Cell Res; 1996 Aug; 227(1):55-62. PubMed ID: 8806451
[TBL] [Abstract][Full Text] [Related]
20. All-trans-retinoic acid inhibits the growth of human rhabdomyosarcoma cell lines.
Crouch GD; Helman LJ
Cancer Res; 1991 Sep; 51(18):4882-7. PubMed ID: 1893378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
